Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
09:39p Teva, Allergan sell product lines to Australian co
05:04p MAYNE PHARMA : expands into US for $889m
08:01a ASTRAZENECA : Announces new antibiotic zavicefta approved in the eur..
SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/08/2012 | 12:11am CEST
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on ALLERGAN, INC.
09:39p Teva, Allergan sell product lines to Australian co
05:04p MAYNE PHARMA : expands into US for $889m
08:01a ASTRAZENECA : Announces new antibiotic zavicefta approved in the european union ..
06/23 ALLERGAN : Announces FDA Approval of Supplemental New Drug Application (sNDA) fo..
06/21 ULTRAGENYX PHARMACEUTICAL : Appoints Karah Parschauer as Executive Vice Presiden..
06/21 ALLERGAN : ZYDUS HEALTHCARE BUYS TWO ANDAs FROM TEVA
06/20 ALLERGAN : 1 Stock to Invest in Big Pharma
06/20 ALLERGAN : Ultragenyx Appoints Karah Parschauer as Executive Vice President, Gen..
06/18 Teva sells products to Sagent Pharma to fulfil Allergan Generics deal conditi..
06/16 IRONWOOD PHARMACEUTICALS : and Allergan Announce Supplemental New Drug Applicati..
Advertisement
Income Statement Evolution
More Financials